Gregory Ferenstein
Gregory Ferenstein is a senior fellow in drug policy at Reason Foundation.
-
Psychedelics Policy Newsletter: A glimpse into Colorado after psychedelics legalization, a gathering of conservative legislators, and more
Plus: Food and Drug Administration approval of MDMA is tentative, the psychedelic origins of Whole Foods, and more.
-
State psychedelics legalization and policy roundup — July 2024
Psychedelics on the ballot in Massachusetts, Colorado proposes new regulatory rules, and Arizona Gov. Hobbs vetoes a psychedelics bill.
-
Colorado could improve regulatory rules regarding psychedelic use
As Colorado establishes an operating regulatory framework for The Natural Medicine Health Act, there is room for improvement in rulemaking.
-
A glimpse into Colorado’s emerging legal pyschedelics scene
Colorado became the first state in America where residents can legally grow and share psilocybin mushrooms in 2022.
-
How the FDA can safely approve a promising but controversial mental health drug
The FDA’s existing processes may be able to address the advisory committee’s worries about the previous tests.
-
States can legalize MDMA for pharmaceutical use even if the federal government does not
States have many options when considering the legalization or decriminalization of psychedelic medicines within their borders.
-
New Jersey Senate Bill 2283 would decriminalize psilocybin
Senate Bill 2283 would allow personal possession and cultivation of psilocybin in a private residence.
-
Psychedelics Policy Newsletter: Massachusetts ballot initiative would foster access, state legislature momentum stalls, and more
Plus: The National Institute of Health awards money for addiction research, a Michigan poll signals interest in psychedelics, and more.
-
State psychedelics legalization and policy roundup — May 2024
Legislative progress slows, a Massachusetts ballot initiative moves forward, and Colorado rejects censorship.
-
Assessing Michigan voters’ support for legalizing psychedelic therapy
An online survey finds 65% of registered voters in Michigan say they support allowing licensed health professionals to legally prescribe psychedelics.
-
California should legalize psychedelics and learn from its marijuana regulation mistakes
The state’s high cannabis taxes and burdensome regulations make legal marijuana products expensive and keep the illicit market thriving.
-
Massachusetts should allow psychedelic therapy
A Massachusetts ballot initiative would create a regulated framework for legal, professionally facilitated psychedelic services and therapy.
-
Colorado’s rejection of Senate Bill 24-158 is good for privacy, free speech
For now, the defeat of Colorado Senate Bill 24-158 was a win for consumers, privacy and free speech.
-
Psychedelics Policy Newsletter: A retail system model, ibogaine research, and legalization updates
A model that would reduce costs and increase consumer access to psychedelics by streamlining the overall regulatory burden.
-
State psychedelics legalization and policy roundup — March 2024
The current state proposals fall into a few broad categories, primarily regulated access and decriminalization of psychedelics.
-
Massachusetts ballot initiative aims to legalize psychedelics
The initiative would legalize guided in-person psychedelic experiences and allow people to grow and consume psychedelics for spiritual or mental health purposes.
-
Nonprofit announces new partnership with Ohio to tackle opioid addiction with ibogaine
A promising new partnership announced in Ohio this week will explore the use of the psychedelic compound ibogaine to treat opioid use disorder.
-
A policy framework for personal psychedelics licenses
Psychedelic licenses for consumers have advantages over the current approach in two U.S. states that rely on professionals to dispense and facilitate services.
